Author

Fabiana Zingone 1

1 University of Padova,Padova,Italy

SWITCHING FROM ADALIMUMAB ORIGINATOR TO ABP 501 BIOSIMILAR: A MULTICENTRIC NORTH ITALIAN STUDY

Linda Cingolani, Brigida Barberio, Fabiana Zingone, Piera Melatti, Lorenzo Bertani, Antonio Ferronato, Alessandro Gubbiotti, Davide Massimi, Cesare Casadei, Greta Lorenzon, Renata D'Incà, Edoardo Vincenzo Savarino

TELEMEDICINE IN THE COVID-19 ERA FOR LIVER TRANSPLANT RECIPIENTS: AN ITALIAN LOCKDOWN AREA EXPERIENCE

Antonella SANTONICOLA, Fabiana Zingone, Silvia Camera, Monica Siniscalchi, Luigi Fortino, Carolina Ciacci

TELEMEDICINE IN THE COVID-19 LOCKDOWN: IMPLEMENTATION FROM 0% TO 100% IN AN ITALIAN CELIAC DISEASE-DEVOTED CLINIC

Carolina Ciacci, Fabiana Zingone, Michela Battipaglia, Luca Maria Capece, Ilaria Cascone, Annamaria Coppola, Francesca Arianna Esposito, carolina gizzi, Francesca Mascolo, Antonella SANTONICOLA

THE ANTI IL-23/IL-12 AGENT USTEKINUMAB IS AN EFFECTIVE AND SAFE INDUCTION THERAPY IN PATIENTS WITH CROHN'S DISEASE REFRACTORY OR INTOLERANT TO ANTI-TNF: A MULTICENTRE ITALIAN STUDY

Alessandro Gubbiotti, Brigida Barberio, Fabiana Zingone, Lorenzo Bertani, Antonio Ferronato, Renato Sablich, Maria Teresa Urbano, Maria Giulia Demarzo, Giorgia Bodini, Andrea Buda, Davide Massimi, Cesare Casadei, Linda Cingolani, Greta Lorenzon, Renata D'Incà, Edoardo Vincenzo Savarino

Item 31 - 34 / 42
1 2 3
4
5